Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Sales, net	$ 22,153	$ 22,556
Cost of sales	8,697	9,038
Gross profit	13,456	13,518
Operating expenses:
Sales and marketing	6,740	7,874
Research and development	2,095	1,193
General and administrative	5,352	6,419
Total operating expenses	14,187	15,486
Operating loss	(731)	(1,968)
Nonoperating income:
Interest income, net	239	66
Net loss	$ (492)	$ (1,902)
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ (0.01)	$ (0.03)
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ (0.01)	$ (0.03)
Basic weighted average common shares outstanding (in shares)	75,230	74,796
Diluted weighted average common shares outstanding (in shares)	75,230	74,796